AM
Ambea AB (publ)
AMBEA.ST · STO
173.80 kr -0.97% (-1.70 kr)
1M +2.81%
Market Cap 14.1B kr
P/E Ratio 17.90x
Div. Yield -
ROE 15.11%
Bulios Fair Price
226.03 kr
30.1% upside
Current Price
173.8 kr
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AMBEA.ST is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
6/9Valuation
79 /100
Cheap P/FCF 6.40x
P/S 0.83x
P/B 2.74x
Growth
74 /100
Growing Rev. growth 8.28%
FCF growth 14.99%
Book val. growth 3.57%
Profitability
53 /100
Moderate Net margin 4.66%
Op. margin 8.74%
FCF margin 13.03%
Quality
51 /100
Average ROE 15.11%
ROA 3.74%
Asset turnover 0.80x
Debt
20 /100
High Current ratio 0.41x
Int. coverage 2.65x
Net debt/EBITDA 4.04x
Stability
99 /100
Stable Rev. volatility 4.09%
EPS volatility 16.20%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AMBEA.ST
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Mark Jensen
Employees
41,000
Headquarters
Solna
Upcoming events
04 NOV
Earnings
Upcoming earnings report